Sino Biopharmaceutical | 1177 - Current Liabilities


Sino Biopharmaceutical reported CNY24.85B in Current Liabilities for its fiscal semester ending in June of 2025.





Current Liabilities Change Date
Akebia Therapeutics USD 162.35M 1.48M Sep/2026
Alaunos Therapeutics USD 864K 269K Jun/2026
Avita Medical AUD 68.71M 6.04M Jun/2026
Cspc Pharmaceutical CNY 10.18B 65.36M Dec/2025
Dianthus Therapeutics USD 28.51M 5.87M Sep/2026
Ionis Pharmaceuticals USD 435.29M 119.65M Sep/2026
IQVIA Holdings USD 7.78B 1.04B Sep/2026
Jiangsu Hengrui CNY 6.9B 2.65B Sep/2026
Moderna USD 2.03B 506M Sep/2026
Organon & Co USD 2.65B 36M Sep/2026
Revvity USD 701.48M 574.88M Sep/2026
Sino Biopharmaceutical CNY 24.85B 5.29B Jun/2025
Tectonic Therapeutic USD 10.37M 2.59M Jun/2026
Viatris USD 6.64B 290.7M Sep/2026
Xeris Pharmaceuticals USD 134.48M 55.09M Sep/2026